Colorado State University Receives Major Donation Towards Cannabinoid Research

February 7, 2020 16:00:08

Cannabinoids have excited researchers for years. They are a group of unique chemicals produced by cannabis, and studies have shown that they have a diverse range of medicinal properties. The most famous one, THC (delta-9 tetrahydrocannabinol), creates the psychoactive high marijuana is famous for. Cannabidiol is another major cannabinoid, and unlike THC, isn’t psychoactive.

CBD is said to be effective against a variety of conditions ranging from high blood pressure and anxiety to chronic pain and insomnia. However, there’s little scientific evidence to back these claims, and while scientists agree that cannabidiol and cannabinoids, in general, have…

Read More >>

About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CBDWire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask Our Editor

CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
Editor@CBDWire.com

CBDWire is part of the InvestorBrandNetwork.